Health
Study shows brilacidin strongly inhibits SARS-CoV-2 in laboratory cell lines – News-Medical.Net
A recent study by US researchers reveals that brilacidin, a small synthetic molecule with peptide-like properties, exerts potent in vitro antiviral activity against…
A recent study by US researchers reveals that brilacidin, a small synthetic molecule with peptide-like properties, exerts potent in vitro antiviral activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – both as a standalone treatment and in combination with FDA-approved remdesivir. The study is currently available on the bioRxiv* preprint server.
SARS-Cov-2, the pathogen and causative agent of coronavirus disease 19 (COVID-19), has been responsible for more than 1.2…
-
Noosa News16 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
General16 hours agoInternal Revenue Service starts cutting 20,000 workers
-
General19 hours agoUK PM talks US tariff response with Albanese and Meloni
-
General22 hours ago‘We are here for you’: PM to bring help to flood zones